https://www.selleckchem.com/products/sh-4-54.html
A total of 127 patients will be included in the study. Patient enrollment started in February 2019. Until December 2020, 100 patients have been included. Mean age was 64.1 ± 9.03, 76% were males and 24% diabetics. The target vessels for PCI were LAD 83%, LCX 6%, and RCA 11%. The final results are expected in 2021. This study will determine the accuracy and precision of the FFR Planner to predict post-PCI FFR in patients with chronic coronary syndromes undergoing percutaneous revascularization. This study will determine the accuracy and
Respect!
Kommentar
Delen
